Ace investor Mukul Agrawal made significant portfolio moves in the September quarter of 2025, adding 10 new stocks and increasing stakes in five existing holdings, while trimming exposure in nine counters and reducing shareholding below the reporting threshold in four others. By the end of the quarter, Agrawal’s portfolio comprised 75 stocks valued at Rs 7,624 crore, up from 62 stocks worth Rs 6,642 crore in June.

Among the new investments, he acquired 5 lakh shares of IFB Industries (Rs 95 crore), 13.38 lakh shares of Osel Devices (Rs 77 crore), 6 lakh shares of Protean eGov Tech (Rs 51 crore), 30 lakh shares of Vikram Engineering (Rs 31 crore), and 20 lakh shares of Laxmi Finance (Rs 30 crore). Other additions included Kilitch Drugs, NR Agarwal Industries, Solarium Green Energy, Unified Data Tech Solutions, and Zelio EMobility, with the ten new stocks totaling Rs 388 crore.

Agrawal also raised stakes in ASM Technologies, Tatva Chintan Pharma, Monolithisch, Zota Healthcare, and WPIL, while reducing holdings in PDS, Sirca Paints, OneSource Specialty Pharma, Pearl Global, Oriental Rail, Infobeans Tech, Kingfa Science, Stanley Lifestyles, and Vasa Denticity. His shareholding in BSE, Mitcon Consultancy, Raghav Productivity, and Sula Vineyards fell below 1%, though it is unclear if he has fully exited.

As of September, his top five holdings were Neuland Laboratories (Rs 630 crore), ASM Technologies (Rs 521 crore), Radico Khaitan (Rs 451 crore), Zota Healthcare (Rs 395 crore), and Nuvama Wealth (Rs 370 crore), highlighting a focused strategy on select high-value counters.